Nanospheres Formulated from l-Tyrosine Polyphosphate Exhibiting Sustained Release of Polyplexes and In Vitro Controlled Transfection Properties
Authors:
- 20 April 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 6 (3) , 986-995
Abstract
Currently, viruses are utilized as vectors for gene therapy, since they transport across cellular membranes, escape endosomes, and effectively deliver genes to the nucleus. The disadvantage of using viruses for gene therapy is their immune response. Therefore, nanospheres have been formulated as a nonviral gene vector by blending l-tyrosine-polyphosphate (LTP) with polyethylene glycol grafted to chitosan (PEG-g-CHN) and linear polyethylenimine (LPEI) conjugated to plasmid DNA (pDNA). PEG-g-CHN stabilizes the emulsion and prevents nanosphere coalescence. LPEI protects pDNA degradation during nanosphere formation, provides endosomal escape, and enhances gene expression. Previous studies show that LTP degrades within seven days and is appropriate for intracellular gene delivery. These nanospheres prepared by water-oil emulsion by sonication and solvent evaporation show diameters between 100 and 600 nm. Also, dynamic laser light scattering shows that nanospheres completely degrade after seven days. The sustained release of pDNA and pDNA-LPEI polyplexes is confirmed through electrophoresis and PicoGreen assay. A LIVE/DEAD cell viability assay shows that nanosphere viability is comparable to that of buffers. X-Gal staining shows a sustained transfection for 11 days using human fibroblasts. This result is sustained longer than pDNA-LPEI and pDNA-FuGENE 6 complexes. Therefore, LTP-pDNA nanospheres exhibit controlled transfection and can be used as a nonviral gene delivery vector.Keywords
This publication has 48 references indexed in Scilit:
- Arthritis gene therapy's first deathArthritis Research & Therapy, 2008
- Properties of l-tyrosine based polyphosphates pertinent to potential biomaterial applicationsPolymer, 2005
- Phagocytosis-mediated retroviral transduction: co-internalization of deactivated retrovirus and calcium-alginate microspheres by macrophagesThe Journal of Gene Medicine, 2004
- Synthesis and characterization of l-tyrosine based novel polyphosphates for potential biomaterial applicationsPolymer, 2004
- In situ single cell observation by fluorescence resonance energy transfer reveals fast intra‐cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimineThe Journal of Gene Medicine, 2004
- Uptake and Intracellular Fate of Polyethylenimine in VivoBiochemical and Biophysical Research Communications, 2000
- GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?Journal of Urology, 2000
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Genetics of common disease: implications for therapy, screening and redefinition of diseasePhilosophical Transactions of the Royal Society B: Biological Sciences, 1997
- An analysis of variance test for normality (complete samples)Biometrika, 1965